{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:40:57Z","timestamp":1759736457975,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"publisher","award":["CPRIT-RP180674"],"award-info":[{"award-number":["CPRIT-RP180674"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.prp.2024.155163","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T09:57:02Z","timestamp":1706781422000},"page":"155163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)"],"prefix":"10.1016","volume":"255","author":[{"given":"Kalyani R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres F.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Urbicain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roma H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Major","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Lopez-Terrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev A.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Woodfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.prp.2024.155163_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29763","article-title":"Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States","volume":"69","author":"Kahla","year":"2022","journal-title":"Pedia Blood Cancer"},{"issue":"4","key":"10.1016\/j.prp.2024.155163_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2022.04.035","article-title":"Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults","volume":"77","author":"Sumazin","year":"2022","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.prp.2024.155163_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023419","article-title":"Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD\/LtSz-scid IL2Rgammanull mice","volume":"6","author":"Ellerkamp","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.prp.2024.155163_bib4","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study","volume":"28","author":"Zsiros","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155163_bib5","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/MPH.0b013e31821f0eaf","article-title":"Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin","volume":"33","author":"Sivaprakasam","year":"2011","journal-title":"J. Pedia Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155163_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10147-013-0616-8","article-title":"Current chemotherapeutic approaches for hepatoblastoma","volume":"18","author":"Watanabe","year":"2013","journal-title":"Int J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2024.155163_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1097-0142(19820701)50:1<97::AID-CNCR2820500118>3.0.CO;2-4","article-title":"Establishment of an experimental model of human hepatoblastoma","volume":"50","author":"Hata","year":"1982","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.prp.2024.155163_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2006.03.018","article-title":"Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice","volume":"45","author":"Schnater","year":"2006","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.prp.2024.155163_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11307-009-0213-4","article-title":"Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model","volume":"11","author":"Ong","year":"2009","journal-title":"Mol. Imaging Biol."},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17665-8","article-title":"A novel cell line based orthotopic xenograft mouse model that recapitulates human hepatoblastoma","volume":"7","author":"Woodfield","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.prp.2024.155163_bib12","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1158\/1535-7163.MCT-21-0758","article-title":"Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, is effective in pediatric malignancies: a report by the pediatric preclinical testing consortium","volume":"21","author":"Hingorani","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-05320-0","article-title":"A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors","volume":"6","author":"Marques Da Costa","year":"2023","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz007","article-title":"Trends in international incidence of pediatric cancers in children under 5 years of age: 1988-2012","volume":"3","author":"Hubbard","year":"2019","journal-title":"JNCI Cancer Spectr."},{"issue":"4","key":"10.1016\/j.prp.2024.155163_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.28621","article-title":"Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management","volume":"64","author":"Nicolle","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2016.04.009","article-title":"Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer","volume":"65","author":"Bissig-Choisat","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020273","article-title":"Animal modeling of pediatric liver cancer","volume":"12","author":"Whitlock","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.prp.2024.155163_bib18","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ijc.32662","article-title":"The fidelity of cancer cells in PDX models: characteristics, mechanism and clinical significance","volume":"146","author":"Shi","year":"2020","journal-title":"Int J. Cancer"},{"issue":"30","key":"10.1016\/j.prp.2024.155163_bib19","doi-asserted-by":"crossref","first-page":"21036","DOI":"10.18632\/oncotarget.24783","article-title":"Increasing aggressiveness of patient-derived xenograft models of cervix carcinoma during serial transplantation","volume":"9","author":"Wegner","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.prp.2024.155163_bib20","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.18632\/oncotarget.6919","article-title":"Patient-derived xenograft (PDX) tumors increase growth rate with time","volume":"7","author":"Pearson","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021590","article-title":"Analysis of serial neuroblastoma PDX passages in mice allows the identification of new mediators of neuroblastoma aggressiveness","volume":"24","author":"Gomez-Munoz","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2024.155163_bib22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/hep4.1365","article-title":"Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors","volume":"3","author":"Blumer","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"5","key":"10.1016\/j.prp.2024.155163_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0168-8278(95)80064-6","article-title":"Proliferation and differentiation of a human hepatoblastoma transplanted in the Nude mouse","volume":"23","author":"Desdouets","year":"1995","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2024.155163_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.21328","article-title":"Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas","volume":"44","author":"Luo","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.humpath.2007.06.006","article-title":"Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases","volume":"39","author":"Zynger","year":"2008","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"38","author":"Zhou","year":"2018","journal-title":"Med Res. Rev."},{"issue":"9","key":"10.1016\/j.prp.2024.155163_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091339","article-title":"Glypican 3-targeted therapy in hepatocellular carcinoma","volume":"11","author":"Nishida","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2024.155163_bib28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer (review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.prp.2024.155163_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14712598.8.3.325","article-title":"Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer","volume":"8","author":"Evdokimova","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.prp.2024.155163_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.2011.213181","article-title":"alpha-Fetoprotein","volume":"96","author":"Murray","year":"2011","journal-title":"Arch. Dis. Child Educ. Pract. Ed."},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.prp.2024.155163_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jfma.2016.09.013","article-title":"Complementary roles of beta-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma","volume":"116","author":"Huang","year":"2017","journal-title":"J. Formos. Med. Assoc."},{"issue":"1-3","key":"10.1016\/j.prp.2024.155163_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tox.2011.01.006","article-title":"Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma","volume":"281","author":"Schmidt","year":"2011","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5858\/arpa.2014-0153-RA","article-title":"Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice","volume":"139","author":"Chen","year":"2015","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.prp.2024.155163_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104762","article-title":"Cytokeratin 7 and cytokeratin 20 expression in cancer: a tissue microarray study on 15,424 cancers","volume":"126","author":"Dum","year":"2022","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2024.155163_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2350\/05-12-0002.1","article-title":"Hepatoblastomas and liver development: a study of cytokeratin immunoexpression in twenty-nine hepatoblastomas","volume":"9","author":"Cajaiba","year":"2006","journal-title":"Pedia Dev. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib37","first-page":"87","article-title":"The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma","volume":"28","author":"Shiran","year":"2006","journal-title":"Malays. J. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2024.155163_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115780","article-title":"Application of immunohistochemistry in the pathological diagnosis of liver tumors","volume":"22","author":"Takahashi","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2024.155163_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gendis.2014.09.004","article-title":"The versatile functions of Sox9 in development, stem cells, and human diseases","volume":"1","author":"Jo","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.prp.2024.155163_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1746-1596-7-44","article-title":"Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma","volume":"7","author":"Guo","year":"2012","journal-title":"Diagn. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2024.155163_bib41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/PAI.0000000000000826","article-title":"Immunohistochemical expression analysis of EpCAM in hepatoblastomas","volume":"28","author":"Lopez-Nunez","year":"2020","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.prp.2024.155163_bib42","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22620","article-title":"Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma","volume":"2","author":"Armeanu-Ebinger","year":"2013","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.prp.2024.155163_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.cdd.4401183","article-title":"Decision making by p53: life, death and cancer","volume":"10","author":"Oren","year":"2003","journal-title":"Cell Death Differ."},{"issue":"22","key":"10.1016\/j.prp.2024.155163_bib44","first-page":"6358","article-title":"p53 gene mutation spectrum in hepatocellular carcinoma","volume":"52","author":"Oda","year":"1992","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2024.155163_bib45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1711760306","article-title":"Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma","volume":"176","author":"Chen","year":"1995","journal-title":"J. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:12:00Z","timestamp":1759734720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":45,"alternative-id":["S0344033824000748"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155163","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155163"}}